Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new …
![HANSIZHUANG Approval for ESCC Treatment](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/09/pexels-tara-winstead-7722797.jpg?resize=760%2C427&ssl=1)
![HANSIZHUANG Approval for ESCC Treatment](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/09/pexels-tara-winstead-7722797.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new …